Provided by Tiger Trade Technology Pte. Ltd.

Vivani Medical, Inc.

1.38
-0.0300-2.13%
Post-market: 1.380.00000.00%19:30 EDT
Volume:104.74K
Turnover:146.97K
Market Cap:124.48M
PE:-3.91
High:1.44
Open:1.44
Low:1.37
Close:1.41
52wk High:1.92
52wk Low:0.9228
Shares:90.20M
Float Shares:36.87M
Volume Ratio:0.35
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3534
EPS(LYR):-0.4265
ROE:-220.40%
ROA:-48.48%
PB:6.56
PE(LYR):-3.24

Loading ...

Vivani Advances GLP-1 Implant Program With Novo Nordisk

TIPRANKS
·
Jul 07

Vivani Medical Jumps as Novo Nordisk Evaluates Weight-loss Drug Implant

Reuters
·
Jul 07

Vivani Medical - to Initiate Phase 1 Study of Npm-139 Semaglutide Implant in Mid-2026

THOMSON REUTERS
·
Jul 07

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate Npm-139, a Miniature, Ultra Long-acting Semaglutide Implant for Chronic Weight Management

THOMSON REUTERS
·
Jul 07

Vivani Medical: no Exclusivity Provisions for Npm-139, or Vivani's Proprietary Nanoportal Technology Associated with Agreement with Novo Nordisk

THOMSON REUTERS
·
Jul 07

Clearone Enters Merger Deal to Acquire Vivani Unit Cortigent

Reuters
·
Jul 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 04

Top Midday Gainers

MT Newswires Live
·
Jul 03

ClearOne enters into merger agreement with Cortigent

TIPRANKS
·
Jul 02

Clearone Set to Trade as Cortigent Holdings Under NASDAQ Ticker CRGT After Vivani Deal Closes

Reuters
·
Jul 02

Clearone Enters Merger Deal to Acquire Vivani Unit Cortigent

Reuters
·
Jul 02

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed Clearone, Inc.

THOMSON REUTERS
·
Jul 02

Vivani Medical Wins Australia Ethics Approval to Start Phase 1 Slim-1 Trial of Semaglutide Implant Npm-139

Reuters
·
Jun 30

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of DR. Dean Baker

THOMSON REUTERS
·
Jun 26

Press Release: Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Dow Jones
·
Jun 26

Vivani Medical Wins Australia Ethics Approval to Launch Slim-1 Semaglutide Implant Trial

Reuters
·
Jun 25

Vivani Medical Receives Regulatory Approval for the Initiation of Slim-1, a Phase 1 Clinical Trial of Npm-139 Semaglutide Implant in Obesity and Chronic Weight Management

THOMSON REUTERS
·
Jun 25

Vivani Medical Initiated at Buy by Lake Street

Dow Jones
·
Jun 23

Lake Street Initiates Coverage on Vivani Medical With Buy Rating, $4 Price Target

MT Newswires Live
·
Jun 23

Vivani Medical CEO Adam Mendelsohn presents at BIO International Convention

Reuters
·
Jun 23